Product Details and Information about Dr. JRK SIVA Herbal Drops, 30 Ml
BENEFITS
Selective targeting and immune modulator.
Boosts disease resistance.
Treats auto-immune predisposition of Psoriasis and vitiligo.
Enhances phagocytosis (engulfs the disease causing microbes).
Improves dendrite cell function and protects the existing functional melanocytes.
HERBS’ UNIQUENESS
Indigofera aspalathoides:
Possess protective effect against carcinogens.
Celastrus paniculatus:
Boosts humoral immunity, increase RBC and WBC count.
Possess anti-oxidant effect.
Corallocarpus epigaeus:
Rich bioflavonoids possess anti-oxidant, anti-helminthic and anti-microbial properties.
Solanum trilobatum:
Effective against several respiratory problems including tuberculosis.
Cinnamomum camphora:
Possess anti-inflammatory activity.
Used in treatment of asthma, arthritis and respiratory ailments.
SCIENTIFIC PROOF
Clinical study with psoriatic patients showed that the combination therapy of oral S.I.V.A herbal drops along with topical application of Dr.JRK’s 777oilhelp in management of psoriasis far more effectively than monotherapy with topical application alone.
Immunomodulatory effect of S.I.V.A herbal drops was found to play an important role in the quick recovery from fungal infections when co-administered with anti-fungal drugs.
In vitro study with fungal cell-ingested macrophage, the death ratio of the macrophages in S.I.V.A treated set revealed the immune boosting abilityof S.I.V.A herbal drops
USAGE INSTRUCTIONS
Adult:
10 drops twice a day in empty stomach
Children
Above 10 years: 5 drops twice a day in empty stomach
Children
5-10 years: 5 drops once a day in empty stomach
(OR)
As directed by the physician.
COMPOSITION
Each 5 gm contains extracts of
Indigofera aspalathoides : 125mg
Celastrus paniculatus : 25mg
Corallocarpus (Bryyonia) epigaeus : 125mg
Cinnamomum camphora : 125mg
Solanum trilobatum : 10mg
Oil base : Q.S.
Drug interactions & contraindications:
There are no known drug interactions and contra-indications
Reviews
There are no reviews yet.